Impact of COVID-19 on the development of detection methods: a narrative review.
DOI:
https://doi.org/10.37868/bes.v4i1.id257Abstract
COVID-19 is without a doubt the most extensively researched infectious disease in history, with over 130,000 PubMed and NCBI citations between January 2020 and September 2023. This compares to around 8,000 citations for influenza and 10,000 citations for tuberculosis during the same period. The value of molecular diagnostics in COVID-19 assessment in terms of lowering morbidity and death is widely acknowledged. This review assesses the impact of COVID-19 on the development of detection methods and emphasizes the specificity and sensitivity of PCR testing.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Husein Djedović

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
This journal permits and encourages authors to post items/PDFs submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.




